HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA FY 2019 Budget Justification Light On Cosmetics Progam Details

This article was originally published in The Rose Sheet

Executive Summary

There’s no new wealth of information on FDA’s cosmetics activities in its justification for proposed fiscal 2019 spending, potentially signaling that cosmetics will remain a low-priority area for the agency.


Related Content

FDA Targets Spring 2019 For Cosmetics Manufacturing Survey; PCPC Input Taken
Feminine Cleanser Marketing Never Without Challenges; Now The Category Has FDA’s Attention
Rep. Pallone Has Cosmetics Concerns, Possibly Coming To A Storefront Near You
FDA To Curtail Cosmetics Safety Work Under FY 2018 Budget Constraints





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts